Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.6 USD | +0.52% | -13.49% | +77.08% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 747M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -101M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.79
x | P/E ratio 2025 * |
-6.91
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Astria Therapeutics, Inc.
1 day | +0.52% | ||
1 week | -13.49% | ||
Current month | -4.36% | ||
1 month | -2.72% | ||
3 months | +73.03% | ||
6 months | +62.68% | ||
Current year | +77.08% |
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 08-06-25 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 11-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 13-12-31 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 19-01-03 |
Director/Board Member | 75 | 16-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 13.6 | +0.52% | 1,537,022 |
24-03-26 | 13.53 | -8.27% | 1,821,338 |
24-03-25 | 14.75 | -2.51% | 4,508,707 |
24-03-22 | 15.13 | -5.38% | 539,887 |
24-03-21 | 15.99 | +1.72% | 1,395,285 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.08% | 747M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.89% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |